TransEnterix (TRXC) Stock Falls After Pricing Public Offering

NEW YORK (TheStreet) -- Shares of TransEnterix (TRXC) were falling 4.5% to $3 on heavy trading volume Friday after the medical devices company priced the 16,666,667 shares of common stock in its public offering.

TransEnterix priced the 16,666,667 shares of common stock in the public offering at $3 a share. The company granted the underwriters of the offering a 30-day option to buy up to 2.5 million shares of common stock.

The offering is expected to close on June 17, 2015.

TransEnterix expects net proceeds of $46.2 million from the offering. The company plans to use the proceeds for research and development, sales, marketing, and commercialization related to its SurgiBot System, working capital and other general corporate purposes.

About 5.4 million shares of TranEnterix were traded by 10:36 a.m. Friday, above the company's average trading volume of about 193,000 shares a day.

TRXC ChartTRXC data by YCharts

More from Markets

Three Big Factors That Rocked the Stock Market Tuesday

Three Big Factors That Rocked the Stock Market Tuesday

Dow Tumbles Over 400 Points; S&P 500 and Nasdaq Also Finish Lower

Dow Tumbles Over 400 Points; S&P 500 and Nasdaq Also Finish Lower

Caterpillar Bulldozes Industrial Sector With Bad News on Earnings Call

Caterpillar Bulldozes Industrial Sector With Bad News on Earnings Call

Jim Cramer: If You're Afraid of the 10-Year Yield, Go to Cash

Jim Cramer: If You're Afraid of the 10-Year Yield, Go to Cash

Eli Lilly CEO Expresses Confidence in New Rheumatoid Arthritis Drug

Eli Lilly CEO Expresses Confidence in New Rheumatoid Arthritis Drug